Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 826 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/21/2008


21.		Phase III Randomized Study of CBDCA/TAX Administered for 3 vs 6 Courses for Selected Stages IA-C and Stages IIA-C Ovarian Epithelial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age				NCI				GOG-157 GOG-0157

Last Modified: 1/15/2008


22.		Phase III Randomized Study of Docetaxel Versus Paclitaxel in Women With Metastatic or Locally Advanced, Inoperable Adenocarcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				AVENTIS-56976-TAX-311 RP-56976-TAX-311, NCI-V95-0680, NCT00002662

Last Modified: 9/1/1995


23.		Phase III Randomized Study of Chemotherapy with vs without Monoclonal Antibody HER2 in Women with Metastatic Breast Cancer Overexpressing HER2/neu and Previously Untreated with Cytotoxic Chemotherapy (Summary Last Modified 09/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Pharmaceutical / Industry				GENENTECH-HO648G NCI-V95-0714

Last Modified: 11/9/2006


24.		Phase III Randomized Study of Paclitaxel vs No Further Chemotherapy Following Doxorubicin/Cyclophosphamide for Resected Node-Positive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 78				NCI				NSABP-B-28 NSABP-B-28

Last Modified: 5/1/1997


25.		Phase III Randomized Study of Losoxantrone/Paclitaxel/G-CSF vs Paclitaxel Alone in Women with Stage IV Breast Cancer (Summary Last Modified 05/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				DUP-941-017 NCI-V95-0785

Last Modified: 8/16/2005


26.		Phase III Randomized Study of TAX/CBDCA vs CBDCA or CAP (CTX/DOX/CDDP) for Advanced Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								MRC-ICON3 EU-95035

Last Modified: 11/26/2007 First Published: 2/1/1996


27.		Phase III Randomized Study of 24 Hour Versus 96 Hour Infusion of Paclitaxel With Cisplatin in Patients With Suboptimal Stage III or IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				GOG-162 NCT00002717, GOG-0162

Last Modified: 1/22/2008


28.		Phase III Randomized Study of TAX/CBDCA vs VNB/CDDP for Stage IV and Selected Stage IIIB non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				SWOG-9509 SWOG-9509

Last Modified: 5/8/2007 First Published: 6/1/1996


29.		NCI HIGH-PRIORITY CLINICAL TRIAL--Phase III Randomized Study of Intensive Sequential Doxorubicin, Paclitaxel, and Cyclophosphamide Versus Doxorubicin and Cyclophosphamide Followed By STAMP I or STAMP V Combination Chemotherapy With Autologous Stem Cell Rescue in Women With Primary Breast Cancer and At Least 4 Involved Axillary Lymph Nodes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Adult				NCI				SWOG-S9623 CLB-9640, E-S9623, NCT00002772, S9623

Last Modified: 6/21/2007


30.		Phase III Randomized Study of Doxorubicin/Cisplatin vs Doxorubicin/Paclitaxel/G-CSF for Primary Stage III/IV or Recurrent Endometrial Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				GOG-163 GOG-0163

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute